Treatments

Abderrahim Benmoussa, phD

Apr 7, 20202 min read

Experimental treatments and controversies, a review

Quality of evidence: C Controversial treatments: an updated understanding of the Coronavirus Disease 2019 Authors: Zhang C et al Journal:...

31 views0 comments

Abderrahim Benmoussa, phD

Apr 7, 20201 min read

Heparin and mortality in patients with coagulopathy, a retrospective cohort study

Quality of evidence: B- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with...

4 views0 comments

Abderrahim Benmoussa, phD

Apr 6, 20201 min read

Early use of short term corticosteroids therapy, an open-label non-randomized monocentric trial

Quality of evidence: C- Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19...

4 views0 comments

Abderrahim Benmoussa, phD

Apr 6, 20201 min read

Anti-inflammatory drugs and severe cases, a review, and expert position from China

Quality of evidence: C+ The Use of Anti-Inflammatory Drugs in the Treatment of People With Severe Coronavirus Disease 2019 (COVID-19):...

4 views0 comments

Abderrahim Benmoussa, phD

Apr 6, 20201 min read

Management of critically ill adults, a guideline summary for practioners

Quality of evidence: B- Management of Critically Ill Adults With COVID-19 Authors: Poston JT et al. Journal: JAMA Objectives: Centralize...

7 views0 comments

Withdrawing renin-angiotensin inhibitors in COVID-19? A short review of the literature

Abderrahim Benmoussa, phD

Apr 5, 20201 min read

Withdrawing renin-angiotensin inhibitors in COVID-19? A short review of the literature

Quality of evidence: D SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Authors:...

5 views0 comments

Abderrahim Benmoussa, phD

Apr 5, 20201 min read

On Ibuprofen-associated risk during COVID-19, a news story

Quality of evidence: C- Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists Authors: Michael Day...

4 views0 comments

Abderrahim Benmoussa, phD

Apr 5, 20201 min read

Liver injury and severe coronavirus infections, a summary of the evidence

Quality of evidence: C+ Liver injury during highly pathogenic human coronavirus infections Authors: Xu L et al. Journal: Liver...

6 views0 comments

Abderrahim Benmoussa, phD

Apr 5, 20201 min read

Treatment of COVID-19-induced myocarditis in a young adult, a case report

Quality of evidence: D Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin Authors: Hu H et al Journal: ...

5 views0 comments

Abderrahim Benmoussa, phD

Apr 5, 20201 min read

Are Hypertension and Diabetes risk factors for COVID-19? A short summary of the evidence

Quality of evidence: C - Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Authors: Fang et...

2 views0 comments

Abderrahim Benmoussa, phD

Apr 5, 20201 min read

QT and Hydroxychloroquine/Azithromycin, a retrospective cohort study

Strength of evidence: C+ The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/Azithromycin Authors:...

29 views0 comments

Abderrahim Benmoussa, phD

Apr 4, 20201 min read

Treatment and prognosis, a retrospective cohort study

Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-

35 views0 comments